[HTML][HTML] Long-term systemic corticosteroid exposure: a systematic literature review

JB Rice, AG White, LM Scarpati, G Wan, WW Nelson - Clinical therapeutics, 2017 - Elsevier
Purpose While corticosteroids are relatively inexpensive and commonly used as treatment
for a variety of conditions, long-term use is known to be associated with certain toxicities …

Glucocorticoid-induced osteoporosis: 2019 concise clinical review

G Adami, KG Saag - Osteoporosis International, 2019 - Springer
Glucocorticoids remain widely used for many medical conditions, and fractures are the most
serious common adverse event related to long-term glucocorticoid use. Glucocorticoid …

Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian bone club

MR Laurent, S Goemaere, C Verroken… - Frontiers in …, 2022 - frontiersin.org
Glucocorticoids are effective immunomodulatory drugs used for many inflammatory
disorders as well as in transplant recipients. However, both iatrogenic and endogenous …

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

S Lekamwasam, JD Adachi, D Agnusdei… - Osteoporosis …, 2012 - Springer
This paper provides a framework for the development of national guidelines for the
management of glucocorticoid-induced osteoporosis in men and women aged 18 years and …

Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions

IEM Bultink, M Baden, WF Lems - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Glucocorticoid-induced osteoporosis (GIOP) is one of the most devastating side-
effects of glucocorticoid (GC) use, as it is associated with an increased fracture risk. The …

Update on glucocorticoid-induced osteoporosis

M Maricic - Rheumatic Disease Clinics, 2011 - rheumatic.theclinics.com
Harvey Cushing first described the association between excess endogenous glucocorticoids
and fractures in 1932. 1 Within a few years after the introduction of prednisone to treat …

Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice

T Thomas, S Horlait, JD Ringe, A Abelson… - Osteoporosis …, 2013 - Springer
This study aims to estimate bisphosphonate effectiveness by comparing fracture incidence
over time on therapy in glucocorticoid-induced osteoporosis (GIO). From this observational …

Glucocorticoid-induced osteoporosis

RA Adler, RS Weinstein, KG Saag - Osteoporosis, 2013 - Elsevier
More than 70 years ago, osteoporosis associated with endogenous glucocorticoid excess
was described by Harvey Cushing. More common is the increased fracture risk associated …

Association of farnesyl diphosphate synthase polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis

Y Liu, H Liu, M Li, P Zhou, X Xing, W Xia… - Chinese medical …, 2014 - journals.lww.com
Background Genetic factors are important in the pathogenesis of osteoporosis, but less is
known about the genetic determinants of osteoporosis treatment. We aimed to explore the …

Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data

X Du, M Li, P Zhu, J Wang, L Hou, J Li, H Meng… - PLoS …, 2018 - journals.plos.org
Background and objective Markov micro-simulation models are being increasingly used in
health economic evaluations. An important feature of the Markov micro-simulation model is …